Accel-Ondansetron ODT recall in Canada: incorrect dosing
In plain language
This recall involves Accel-Ondansetron ODT 4 & 8 mg sold in Canada. It's being recalled due to concerns with bioequivalence data that could lead to incorrect dosing. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Return the affected products to your local pharmacy for a replacement and proper disposal.
- Consult a health care professional if you have used the affected product and have health concerns.
- Contact Accel Pharma Inc. if you have questions about the recall.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Accel-Ondansetron ODT 4 mg
Lot: CDX00123
Accel-Ondansetron ODT 8 mg
Lot: CEA00123
Why this matters
Incorrect dosing
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: CDX00123, CEA00123
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Incorrect dosing
What should consumers do?
Stop using the product immediately. Return the affected products to your local pharmacy for a replacement and proper disposal. Consult a health care professional if you have used the affected product and have health concerns. Contact Accel Pharma Inc. if you have questions about the recall.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Incorrect dosing
When was this product recalled?
This product was recalled on June 18, 2025.
Is the Accel Pharma Inc. brand affected by this recall?
Yes, Accel Pharma Inc. products are affected by this recall. This recall involves Accel-Ondansetron ODT 4 & 8 mg sold in Canada. It's being recalled due to concerns with bioequivalence data that could lead to incorrect dosing. Stop using the product and follow the return steps in the official notice.